UBS Group’s Omega Healthcare OHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-37,000
Closed -$1.34M 9331
2020
Q4
$1.34M Buy
+37,000
New +$1.25M ﹤0.01% 3768
2018
Q2
Sell
-301,700
Closed -$8.16M 8168
2018
Q1
$8.16M Buy
+301,700
New +$8.05M ﹤0.01% 1875
2017
Q3
Sell
-122,100
Closed -$4.03M 7911
2017
Q2
$4.03M Buy
+122,100
New +$4.04M ﹤0.01% 2348
2015
Q1
Sell
-200
Closed -$8K 9181
2014
Q4
$8K Buy
+200
New +$7.58K ﹤0.01% 8594

Other funds holding OHI

UBS Group's OHI Position: Q1 2026 in Review

UBS Group reduced its Omega Healthcare (OHI) stake by 20% in Q1 2026, selling an estimated $16.3M and leaving 1,470,636 shares worth $64.4M. The position accounts for 0.01% of the portfolio, ranked #1390.

UBS Group first reported a position in OHI in Q4 2014 and has held it in 46 quarters since. The position peaked at $81.1M in Q4 2025. 743 funds tracked by Wall St. Rank hold OHI as of Q1 2026.

  • UBS Group held 1,470,636 shares of Omega Healthcare worth $64.4M as of Q1 2026.
  • UBS Group sold 358,019 Omega Healthcare shares in Q1 2026, an estimated $16.3M.
  • Omega Healthcare made up 0.01% of UBS Group's portfolio in Q1 2026, its #1390 holding.
  • UBS Group first reported a position in Omega Healthcare in Q4 2014 and has held it in 46 quarters since.
  • UBS Group's Omega Healthcare position peaked at $81.1M in Q4 2025.
  • 743 funds tracked by Wall St. Rank held Omega Healthcare as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.